Seven years of botulinum toxin type A in the treatment of neurogenic detrusor hyperactivity;7 Jahre botulinum-A-toxin in der behandlung der neurogenen detrusorhyperaktivität

Urologe - Ausgabe A

Volumn 46, Issue 9, 2007, Pages 1211-1218

  Stohrer M ^a,b   Wolff, A ^a   Kramer, G ^a   Steiner, R ^a   Lochner Ernst D ^a   Leuth, D ^a   Steude, U ^a   Rubben H ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Anticholinergic medications; Botulinum toxin type A; Detrusor hyperactivity; Minimally invasive procedure

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ANTIBODY PRODUCTION; ARTICLE; BLADDER SURGERY; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONSERVATIVE TREATMENT; CYSTOMETRY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MINIMALLY INVASIVE SURGERY; NEUROGENIC BLADDER; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URODYNAMICS;

ADMINISTRATION, INTRAVESICAL; ADULT; BOTULINUM TOXIN TYPE A; CYSTOSCOPY; DATABASES, FACTUAL; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 34648840248     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1507-2     Document Type: Article

References (19)

1. Van Ermengem E (1897) Über einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Z Hyg Infektionskrankh 26: 1-56
2. Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Arch Ophthalmol 87: 1044-1049
3. Blasi J, Chapman ER, Link E et al. (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365: 160-163
4. Dykstra DD, Sidi AA, Scott AB et al. (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139: 919-922
5. Stöhrer M, Schurch B, Kramer G et al. (1999) Botulinum A-toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: A new alternative to medical and surgical procedures? Neurourol Urodyn 18: 401-402
6. Stöhrer M, Goepel M, Kondo A et al. (1999) The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 18: 139-158
7. Abrams P, Cardozo L, Fall M et al. (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 21: 167-178
8. Reitz A, Stöhrer M, Kramer G et al. (2003) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for neurogenic incontinence. J Urol 169(Suppl): 373
9. Schurch B, Stöhrer M, Kramer G et al. (2001) Botulinum toxin-A to treat detrusor hyperreflexia in spinal cord injured patients. Neurourol Urodyn 20: 521-522
10. Chancellor MB, O'Leary M, Erickson J et al. (2003) Successful use of bladder botulinum toxin injection to treat refractory overactive bladder. J Urol 169(Suppl): 351
11. Thavaseelan J (ed) (2005) Botulinum Toxin in Urology State-of-the art lecture. AUA, San Antonio
12. Schulte-Baukloh H, Michael T, Sturzebecher B, Knispel HH (2003) Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44: 139-143
13. Del Popolo G (2001) Botulinum-A toxin in the treatment of detrusor hyperreflexia. Neurourol Urodyn 20: 522-524
14. Rackley R, Abdelmalak J (2004) Urologic application of Botulinum toxin therapy for voiding dysfunction current. Urol Rep 5: 381-388
15. Stöhrer M, Castro-Diaz D, Chartier-Kastler E et al. (2003) EAU Guidelines on neurogenic lower urinary tract dysfunction. EAU 2003
16. Schurch B, Reitz A, Tenti G (2004) Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor. Spinal Cord 42: 338-341
17. Haferkamp A, Schurch B, Reitz A et al. (2004) Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder Eur Urol 46: 784-791
18. Wyndaele JJ, Van Dromme SA (2002) Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40: 599-600
19. Zerman DH, Ishigooka M, Schubert J, Schmidt RA (2001) Trigonum and bladder base injection of botulinum toxin A (BTX) in patients with severe urgency-frequency-syndrome refractory to conservative medical treatment and electrical stimulation. Neurourol Urodyn 20: 412